TrademarkDir
H HYMT HY MEDICAL TECHNOLOGIES
DEAD

Serial Number

87722430

Owner

HY Medical Technologies Inc.

Attorney

Joanna Y. Tsai

First Use Date

Sep 1, 2018

Filing Date

Dec 15, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

H HYMT HY MEDICAL TECHNOLOGIES Trademark

Serial Number: 87722430 • Registration: 5716935

H HYMT HY MEDICAL TECHNOLOGIES is a trademark filed by HY Medical Technologies Inc. on December 15, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

HY Medical Technologies Inc.

6555 Nancy Ridge Dr. Suite 300
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

December 15, 2017

Registration Date

April 2, 2019

First Use Anywhere

September 1, 2018

First Use in Commerce

September 1, 2018

Published for Opposition

May 15, 2018

Cancellation Date

October 17, 2025

Goods & Services

Biological fungicides; Biological herbicides; Biological implants, namely, a vital processed human or animal connective tissue; Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Biological tissue grafts; Pharmaceutical agents affecting metabolism; Pharmaceutical agents for epidermis; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical products and preparations for chloasma; Pharmaceutical skin lotions; Alcohol for pharmaceutical purposes; Analgesic and muscle relaxant pharmaceutical preparations; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Bromine for pharmaceutical purposes; Charcoal for pharmaceutical purposes; Creosote for pharmaceutical purposes; Cytostatics for pharmaceutical purposes; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Ferments for pharmaceutical purposes; Flaxseed for pharmaceutical purposes; Flour for pharmaceutical purposes; Iodine for pharmaceutical purposes; Liquorice for pharmaceutical purposes; Meal for pharmaceutical purposes; Menthol for pharmaceutical purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Pepsins for pharmaceutical purposes; Propolis for pharmaceutical purposes; Starch for pharmaceutical purposes; Turpentine for pharmaceutical purposes; Yeast for pharmaceutical consumption

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 17, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 2, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 2, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 26, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 23, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 31, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 31, 2019 AITU
USE AMENDMENT FILED
Jan 7, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 7, 2019 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 10, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 15, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 15, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 25, 2018 NONP
ASSIGNED TO LIE
Apr 9, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 2, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 2, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 2, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 2, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 2, 2018 CNEA
ASSIGNED TO EXAMINER
Mar 27, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 2, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2017 NWOS
NEW APPLICATION ENTERED
Dec 19, 2017 NWAP

Related Trademarks